Thrombolytic therapy for acute ischemic stroke - The CAEP Position Statement: another perspective. by Hill, MD, Gubitz, G, Phillips, S, Buchan, A

The CAEP Position Statement: Another perspective by Hill, MD, Gubitz, G, Phillips, S, Buchan, A

The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3])... by Sandercock, P, Wardlaw, J, Lindley, R, Dennis, M, Cohen, G, Murray, G, Innes, K, Venables, G, Czlonkowska, A, Kobayashi, A, Ricci, S, Murray, V, Berge, E, Slot, K, Hankey, G, Correia, M, Peeters, A, Matz, K, Lyrer, P, Gubitz, G, Phillips, S, Arauz, A